169 related articles for article (PubMed ID: 37474248)
1. Long-term Prophylaxis Against Aerosolized Marburg Virus in Nonhuman Primates With an Afucosylated Monoclonal Antibody.
Abelson D; Barajas J; Stuart L; Kim D; Marimuthu A; Hu C; Yamamoto B; Ailor E; Whaley KJ; Vu H; Agans KN; Borisevich V; Deer DJ; Dobias NS; Woolsey C; Prasad AN; Peel JE; Lawrence WS; Cross RW; Geisbert TW; Fenton KA; Zeitlin L
J Infect Dis; 2023 Nov; 228(Suppl 7):S701-S711. PubMed ID: 37474248
[TBL] [Abstract][Full Text] [Related]
2. Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges).
Dye JM; Warfield KL; Wells JB; Unfer RC; Shulenin S; Vu H; Nichols DK; Aman MJ; Bavari S
Viruses; 2016 Apr; 8(4):94. PubMed ID: 27070636
[TBL] [Abstract][Full Text] [Related]
3. Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA.
Thi EP; Mire CE; Ursic-Bedoya R; Geisbert JB; Lee ACH; Agans KN; Robbins M; Deer DJ; Fenton KA; MacLachlan I; Geisbert TW
Sci Transl Med; 2014 Aug; 6(250):250ra116. PubMed ID: 25143366
[TBL] [Abstract][Full Text] [Related]
4. Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.
Geisbert TW; Geisbert JB; Leung A; Daddario-DiCaprio KM; Hensley LE; Grolla A; Feldmann H
J Virol; 2009 Jul; 83(14):7296-304. PubMed ID: 19386702
[TBL] [Abstract][Full Text] [Related]
5. Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates.
Mire CE; Geisbert JB; Agans KN; Satterfield BA; Versteeg KM; Fritz EA; Feldmann H; Hensley LE; Geisbert TW
PLoS One; 2014; 9(4):e94355. PubMed ID: 24759889
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional profiling of immune responses in NHPs after low-dose, VSV-based vaccination against Marburg virus.
Prator CA; Dorratt BM; O'Donnell KL; Lack J; Pinski AN; Ricklefs S; Martens CA; Messaoudi I; Marzi A
Emerg Microbes Infect; 2023 Dec; 12(2):2252513. PubMed ID: 37616377
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus.
Bixler SL; Bocan TM; Wells J; Wetzel KS; Van Tongeren SA; Dong L; Garza NL; Donnelly G; Cazares LH; Nuss J; Soloveva V; Koistinen KA; Welch L; Epstein C; Liang LF; Giesing D; Lenk R; Bavari S; Warren TK
Antiviral Res; 2018 Mar; 151():97-104. PubMed ID: 29289666
[TBL] [Abstract][Full Text] [Related]
8. Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus Disease.
Marzi A; Jankeel A; Menicucci AR; Callison J; O'Donnell KL; Feldmann F; Pinski AN; Hanley PW; Messaoudi I
Front Immunol; 2021; 12():774026. PubMed ID: 34777392
[TBL] [Abstract][Full Text] [Related]
9. Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment.
Daddario-DiCaprio KM; Geisbert TW; Ströher U; Geisbert JB; Grolla A; Fritz EA; Fernando L; Kagan E; Jahrling PB; Hensley LE; Jones SM; Feldmann H
Lancet; 2006 Apr; 367(9520):1399-404. PubMed ID: 16650649
[TBL] [Abstract][Full Text] [Related]
10. Development of an Immunochromatography Assay to Detect Marburg Virus and Ravn Virus.
Changula K; Kajihara M; Muramatsu S; Hiraoka K; Yamaguchi T; Yago Y; Kato D; Miyamoto H; Mori-Kajihara A; Shigeno A; Yoshida R; Henderson CW; Marzi A; Takada A
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140590
[TBL] [Abstract][Full Text] [Related]
11. A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates.
Hunegnaw R; Honko AN; Wang L; Carr D; Murray T; Shi W; Nguyen L; Storm N; Dulan CNM; Foulds KE; Agans KN; Cross RW; Geisbert JB; Cheng C; Ploquin A; Stanley DA; Geisbert TW; Nabel GJ; Sullivan NJ
Sci Transl Med; 2022 Dec; 14(675):eabq6364. PubMed ID: 36516269
[TBL] [Abstract][Full Text] [Related]
12. AAV-Vectored Expression of Marburg Virus-Neutralizing Antibody MR191 Provides Complete Protection From Challenge in a Guinea Pig Model.
Rghei AD; Cao W; He S; Lopes JA; Zielinska N; Pei Y; Thompson B; Banadyga L; Wootton SK
J Infect Dis; 2023 Nov; 228(Suppl 7):S682-S690. PubMed ID: 37638865
[TBL] [Abstract][Full Text] [Related]
13. Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs.
Fusco ML; Hashiguchi T; Cassan R; Biggins JE; Murin CD; Warfield KL; Li S; Holtsberg FW; Shulenin S; Vu H; Olinger GG; Kim DH; Whaley KJ; Zeitlin L; Ward AB; Nykiforuk C; Aman MJ; Berry JD; Saphire EO
PLoS Pathog; 2015 Jun; 11(6):e1005016. PubMed ID: 26115029
[TBL] [Abstract][Full Text] [Related]
14. Immune Response to Marburg Virus Angola Infection in Nonhuman Primates.
Fernando L; Qiu X; Melito PL; Williams KJ; Feldmann F; Feldmann H; Jones SM; Alimonti JB
J Infect Dis; 2015 Oct; 212 Suppl 2():S234-41. PubMed ID: 25957966
[TBL] [Abstract][Full Text] [Related]
15. Preexisting Immunity Does Not Prevent Efficacy of Vesicular Stomatitis Virus-Based Filovirus Vaccines in Nonhuman Primates.
Marzi A; Feldmann F; O'Donnell KL; Hanley PW; Messaoudi I; Feldmann H
J Infect Dis; 2023 Nov; 228(Suppl 7):S671-S676. PubMed ID: 37290042
[TBL] [Abstract][Full Text] [Related]
16. Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses.
Swenson DL; Warfield KL; Larsen T; Alves DA; Coberley SS; Bavari S
Expert Rev Vaccines; 2008 May; 7(4):417-29. PubMed ID: 18444889
[TBL] [Abstract][Full Text] [Related]
17. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the Cynomolgus Macaque Model of Marburg Virus Disease and Assessment of Timing for Therapeutic Treatment Testing.
Zumbrun EE; Garvey CB; Wells JB; Lynn GC; Van Tongeren S; Steffens JT; Wetzel KS; Gomba LM; O'Brien KA; Rossi FD; Zeng X; Lee ED; Raymond JLW; Hoffman DA; Jay AN; Brown ES; Kallgren PA; Norris SL; Cantey-Kiser J; Kudiya H; Arthur C; Blair C; Babusis D; Chu VC; Singh B; Bannister R; Porter DP; Cihlar T; Dye JM
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140576
[TBL] [Abstract][Full Text] [Related]
19. Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease.
Dye JM; Herbert AS; Kuehne AI; Barth JF; Muhammad MA; Zak SE; Ortiz RA; Prugar LI; Pratt WD
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):5034-9. PubMed ID: 22411795
[TBL] [Abstract][Full Text] [Related]
20. Temporal Characterization of Marburg Virus Angola Infection following Aerosol Challenge in Rhesus Macaques.
Lin KL; Twenhafel NA; Connor JH; Cashman KA; Shamblin JD; Donnelly GC; Esham HL; Wlazlowski CB; Johnson JC; Honko AN; Botto MA; Yen J; Hensley LE; Goff AJ
J Virol; 2015 Oct; 89(19):9875-85. PubMed ID: 26202230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
